Herold Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-50
Closed -$3.61K 621
2022
Q1
$3.61K Buy
+50
New +$3.6K ﹤0.01% 688
2021
Q4
Sell
-50
Closed -$6K 596
2021
Q3
$6K Buy
+50
New +$7.28K ﹤0.01% 656

Other funds holding TDOC

Herold Advisors's TDOC Position: Q2 2022 in Review

Herold Advisors sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 50 shares — an estimated $3.61K sold.

Herold Advisors first reported a position in TDOC in Q3 2021 and held it in 2 quarters. The position peaked at $6K in Q3 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Herold Advisors reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Herold Advisors sold 50 Teladoc Health shares in Q2 2022, an estimated $3.61K.
  • Herold Advisors first reported a position in Teladoc Health in Q3 2021 and held it in 2 quarters.
  • Herold Advisors's Teladoc Health position peaked at $6K in Q3 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Herold Advisors's 13F filing for Q2 2022, filed 15 Jul 2022.